A Phase 2 Study of Trastuzumab in Combination With BMS-247550 in Women With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2013
At a glance
- Drugs Ixabepilone (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 09 Jan 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Oct 2007 Status changed from in progress to recruiting
- 29 Aug 2005 New trial record.